Table 1 Demographic and clinical features of CRC patients and healthy subjectsa.
From: Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
Variables | Internal Validation set (n = 85) | Independent Validation set (n = 90) | Healthy Subjects (n = 130) |
|---|---|---|---|
Age (years) | |||
Mean (SD) | 58.7(12.3) | 56.6(10.7) | 54.1(7.5) |
≥65, No. | 26 | 28 | 51 |
<65,No. | 60 | 62 | 79 |
Sex, No. | |||
Male | 53 | 60 | 70 |
Female | 32 | 30 | 50 |
Follow-up time, months | |||
Median | 36.0 | 32.0 | |
Range | 33.0–38.1 | 27.5–35.0 | |
Recurrence rates | |||
1 year | 13/85 | 10/89 | |
3 year | 19/85 | 23/89 | |
Histological grade, No. | |||
Middle-Low | 76 | 74 | |
High | 9 | 16 | |
Tumor location, No. | |||
Colon | 37 | 37 | |
Rectum | 49 | 53 | |
TNM stage, No. | |||
II | 52 | 49 | |
III | 34 | 41 | |
Adjuvant chemotherapy | |||
Received | 37 | 43 | |
Did not received | 48 | 42 | |
